{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T03:07:05Z","timestamp":1788059225000,"version":"build-2784847793"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcrc.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:37:21Z","timestamp":1596195441000},"page":"328-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study"],"prefix":"10.1016","volume":"60","author":[{"given":"Fahad","family":"Faqihi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alodat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios J.","family":"Kutsogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Brindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karakitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2020.07.001_bb0005","series-title":"WHO Middle East respiratory syndrome coronavirus (MERS-CoV) summary and literature update","year":"2014"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0010","series-title":"CDC Middle East Respiratory Syndrome (MERS)","year":"2014"},{"issue":"10224","key":"10.1016\/j.jcrc.2020.07.001_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jcrc.2020.07.001_bb0020","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China. China Medical Treatment Expert Group for Covid-19","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"10229","key":"10.1016\/j.jcrc.2020.07.001_bb0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0030","unstructured":"Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; 6 April."},{"issue":"24","key":"10.1016\/j.jcrc.2020.07.001_bb0035","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate Use of Remdesivir for Patients with Severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"issue":"10236","key":"10.1016\/j.jcrc.2020.07.001_bb0040","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicenter trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0045","first-page":"1","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0050","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"19","key":"10.1016\/j.jcrc.2020.07.001_bb0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of Lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jcrc.2020.07.001_bb0060","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"10.1016\/j.jcrc.2020.07.001_bb0065","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0070","article-title":"Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcrc.2020.07.001_bb0075","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/CM9.0000000000000824","article-title":"Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study","volume":"133","author":"Deng","year":"2020","journal-title":"Chin Med J"},{"issue":"2","key":"10.1016\/j.jcrc.2020.07.001_bb0080","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PCC.0b013e3181e2a569","article-title":"Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock","volume":"12","author":"Patel","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13054-018-2220-9","article-title":"Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers","volume":"22","author":"Knaup","year":"2018","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.jcrc.2020.07.001_bb0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0095","author":"Saudi Ministry of Health"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0100","author":"Saudi Ministry of Health"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0105","unstructured":"World Health Organization, Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim guidance. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infectionwhen-novel-coronavirus-(ncov)-infection-is-suspected."},{"issue":"315(8)","key":"10.1016\/j.jcrc.2020.07.001_bb0115","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries","volume":"23","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jcrc.2020.07.001_bb0120","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00134-012-2682-1","article-title":"The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material","volume":"38","author":"Ferguson","year":"2012","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jcrc.2020.07.001_bb0125","first-page":"557","article-title":"Soares M. ICU severity of illness scores: APACHE, SAPS and MPM","volume":"20","author":"Salluh","year":"2014","journal-title":"Curr Opin Crit Care"},{"issue":"3","key":"10.1016\/j.jcrc.2020.07.001_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"International Guidelines for Management of Sepsis and Septic Shock","volume":"43","author":"Rhodes","year":"2016","journal-title":"Intensive Care Med 2017"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0135","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","article-title":"The surviving sepsis campaign bundle: 2018 update","volume":"44","author":"Levy","year":"2018","journal-title":"Intensive Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2020.07.001_bb0140","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"issue":"6490","key":"10.1016\/j.jcrc.2020.07.001_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00557-20","article-title":"Comparative performance of SARS-CoV-2 detection assays using seven different primer\/probe sets and one assay kit","volume":"58","author":"Nalla","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"7809","key":"10.1016\/j.jcrc.2020.07.001_bb0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.jcrc.2020.07.001_bb0160","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cca.2020.03.009","article-title":"Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020","volume":"505","author":"Liu","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"5","key":"10.1016\/j.jcrc.2020.07.001_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00310-20","article-title":"Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp\/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens","volume":"58","author":"Chan","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jcrc.2020.07.001_bb0175","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"20","key":"10.1016\/j.jcrc.2020.07.001_bb0180","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jcrc.2020.07.001_bb0190","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ekir.2019.09.007","article-title":"2017 kidney disease: improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update implementation: Asia summit conference report","volume":"4","author":"Wang","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"14","key":"10.1016\/j.jcrc.2020.07.001_bb0195","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.jcrc.2020.07.001_bb0200","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","article-title":"Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial","volume":"44","author":"Klein","year":"2018","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2020.07.001_bb0205","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00134-005-2815-x","article-title":"Early isovolaemic haemofiltration in oliguric patients with septic shock","volume":"32","author":"Piccinni","year":"2006","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.jcrc.2020.07.001_bb0210","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00134-003-1796-x","article-title":"Coupled plasma filtration adsorption","volume":"29","author":"Bellomo","year":"2003","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2020.07.001_bb0215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00003246-200201000-00016","article-title":"A phase II randomized, controlled trial of continuous hemofiltration in sepsis","volume":"30","author":"Cole","year":"2002","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcrc.2020.07.001_bb0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.medin.2016.10.005","article-title":"Plasmapheresis and other extracorporeal filtration techniques in critical patients","volume":"41","author":"Daga Ruiz","year":"2017","journal-title":"Med Intensiva"},{"issue":"2","key":"10.1016\/j.jcrc.2020.07.001_bb0225","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jca.21765","article-title":"Comparison of cytokine changes in three different lipoprotein apheresis systems in an ex vivo whole blood model","volume":"35","author":"Hardersen","year":"2020","journal-title":"J Clin Apher"},{"issue":"1","key":"10.1016\/j.jcrc.2020.07.001_bb0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.autrev.2015.08.010","article-title":"Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review","volume":"15","author":"Kronbichler","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.jcrc.2020.07.001_bb0235","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jca.21370","article-title":"Role of therapeutic apheresis in infectious and inflammatory diseases: current knowledge and unanswered questions","volume":"30","author":"Sloan","year":"2015","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0240","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1309\/AJCP8O8GIPPPNUSH","article-title":"Critical values in the coagulation laboratory: results of a survey of the north American specialized coagulation laboratory association","volume":"136","author":"Pai","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"10223","key":"10.1016\/j.jcrc.2020.07.001_bb0245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jcrc.2020.07.001_bb0250","first-page":"4539","article-title":"Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"24","author":"Meo","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0255","article-title":"Chloroquine and hydroxychloroquine in covid-19","volume":"369","author":"Ferner","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0265","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","author":"Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jcrc.2020.07.001_bb0270","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0275","article-title":"Autopsy Findings and Venous Thromboembolism in Patients With COVID-19","author":"Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0285","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-020-02931-5","article-title":"Severe pulmonary embolism in COVID-19 patients: a call for increased awareness","volume":"24","author":"H\u00e9kimian","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13054-020-03025-y","article-title":"Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study","volume":"24","author":"Fraiss\u00e9","year":"2020","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.jcrc.2020.07.001_bb0295","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/01.CCM.0000277041.13090.0A","article-title":"Acute kidney injury in the intensive care unit according to RIFLE","volume":"35","author":"Ostermann","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2020.02.017","article-title":"Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARSCoV- 2","volume":"80","author":"Xu","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0305","first-page":"200343","article-title":"Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing","author":"Xie","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0310","first-page":"200642","article-title":"Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases","author":"Ai","year":"2020","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.jcrc.2020.07.001_bb0315","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1096\/fj.202000919","article-title":"Rethinking the role of hydroxychloroquine in the treatment of COVID-19","volume":"34","author":"Meyerowitz","year":"2020","journal-title":"FASEB J"},{"issue":"15","key":"10.1016\/j.jcrc.2020.07.001_bb0320","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/cid\/ciaa321","article-title":"Could chloroquine \/hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment?","volume":"71","author":"Guastalegname","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcrc.2020.07.001_bb0325","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/M20-1334","article-title":"Use of hydroxychloroquine and chloroquine during the COVID-19 pandemic: what every clinician should know","volume":"172","author":"Yazdany","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0330","first-page":"e208630","article-title":"Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0335","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality","author":"Zhang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0340","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","author":"Liu","year":"2020","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.jcrc.2020.07.001_bb0345","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: A single center experience","volume":"92","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0350","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.AID-0022-2014","article-title":"Dengue antibody-dependent enhancement: Knowns and unknowns","volume":"2","author":"Halstead","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"15","key":"10.1016\/j.jcrc.2020.07.001_bb0355","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/jama.2020.2783","article-title":"Positive RT-PCR Test Results in Patients Recovered From COVID-19","volume":"323","author":"Lan","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.jcrc.2020.07.001_bb0360","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Puja","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0365","first-page":"102537","article-title":"Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated Intravascular coagulation","volume":"19","author":"McGonagle","year":"2020","journal-title":"Lancet Rheum"},{"issue":"1","key":"10.1016\/j.jcrc.2020.07.001_bb0370","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"The Science Underlying COVID-19: Implications for the Cardiovascular System","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jcrc.2020.07.001_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2020.05.008","article-title":"QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review","author":"Jankelson","year":"2020","journal-title":"Heart Rhythm."},{"issue":"4","key":"10.1016\/j.jcrc.2020.07.001_bb0380","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00059-020-04924-0","article-title":"Arrhythmias and sudden cardiac death in the COVID-19 pandemic","volume":"45","author":"Kuck","year":"2020","journal-title":"Herz"},{"issue":"20","key":"10.1016\/j.jcrc.2020.07.001_bb0385","article-title":"Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans","volume":"S1547-5271","author":"Giudicessi","year":"2020","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.jcrc.2020.07.001_bb0390","doi-asserted-by":"crossref","first-page":"e008662","DOI":"10.1161\/CIRCEP.120.008662","article-title":"The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection","volume":"13","author":"Saleh","year":"2020","journal-title":"Circ Arrhythm Electrophysiol."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412030602X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394412030602X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:48:49Z","timestamp":1760125729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394412030602X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":76,"alternative-id":["S088394412030602X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.07.001","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic plasma exchange in adult critically ill patients with life-threatening SARS-CoV-2 disease: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}